Stock Track | Everest Medicines Plummets 5.04% on Controlling Shareholder's Block Trade

Stock Track

Jan 09, 2025

Everest Medicines (HKG:1952), a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.

The significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading volume fluctuations.

However, the company has clarified that this event does not impact its operations or financial position. CBC Group still retains over 34% ownership in Everest Medicines, and the executives did not participate in the share sale.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1160380170"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1160380170\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1160380170?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-09 13:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160380170","market":"us","top_or_hot":-1,"title":"Stock Track | Everest Medicines Plummets 5.04% on Controlling Shareholder's Block Trade","media":"Stock Track","content":"<p>Everest Medicines (HKG:1952), a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.</p>\n\n<p>The significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading volume fluctuations.</p>\n\n<p>However, the company has clarified that this event does not impact its operations or financial position. CBC Group still retains over 34% ownership in Everest Medicines, and the executives did not participate in the share sale.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Everest Medicines Plummets 5.04% on Controlling Shareholder's Block Trade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Everest Medicines Plummets 5.04% on Controlling Shareholder's Block Trade\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-01-09 13:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Everest Medicines (HKG:1952), a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.</p>\n\n<p>The significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading volume fluctuations.</p>\n\n<p>However, the company has clarified that this event does not impact its operations or financial position. CBC Group still retains over 34% ownership in Everest Medicines, and the executives did not participate in the share sale.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01952","symbol_name":"云顶新耀","start_time":0,"source_url":"","article_id":"1160380170","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160380170","pubTimestamp":1736399074,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Everest Medicines , a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.The significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01952":"云顶新耀"},"translate_title":"股票赛道珠峰医药因控股股东大宗交易暴跌5.04%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"Everest Medicines (HKG:1952), a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.\nThe significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading volume fluctuations.\nHowever, the company has clarified that this event does not impact its operations or financial position. CBC Group still retains over 34% ownership in Everest Medicines, and the executives did not participate in the share sale.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}